SCHEMBL11416554

SCHEMBL11416554

CCCCC(CC)C(=O)O[SnH]

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 9/20 0.73
CA1 P00915 4/20 0.73
MAPK1 P28482 2/20 0.61
ATM Q13315 2/20 0.45
GAA P10253 1/20 0.45
XBP1 P17861 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
TSHR P16473 3/20 0.44
CYP3A4 P08684 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
SLC1A3 P43003 1/20 0.42
SLC1A2 P43004 1/20 0.42
SLC1A1 P43005 1/20 0.42
USP2 O75604 1/20 0.41
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
MAPT P10636 1/20 0.39
KMT2A Q03164 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21924959 1.00 CA2 (0.73) CA2CA1MAPK1ATMGAA
SCHEMBL5480200 0.87 CA2 (0.68) CA2CA1MAPK1ATMGAA
SCHEMBL631533 0.86 CA2 (0.73) CA2CA1MAPK1ATMGAA
SCHEMBL240950 0.86 CA2 (0.73) CA2CA1MAPK1ATMGAA
SCHEMBL11828132 0.84 CA2 (0.70) CA2CA1MAPK1ATMGAA
SCHEMBL21331329 0.84 CA2 (0.70) CA2CA1MAPK1ATMGAA
SCHEMBL2550949 0.84 CA2 (0.70) CA2CA1MAPK1ATMGAA
SCHEMBL17617151 0.84 CA2 (0.70) CA2CA1MAPK1ATMGAA
SCHEMBL1505758 0.84 CA2 (0.70) CA2CA1MAPK1ATMGAA
SCHEMBL2405187 0.84 CA2 (0.70) CA2CA1MAPK1ATMGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260061093-A1 LIPID ANALOGS, LIPOSOMES COMPRISING SAME AND USES THEREOF LIPOSPHERE LTD. (IL) 2026-03-05 US disclosed
EP-4580588-A1 LIPOSOME-CONTAINING COSMETIC COMPOSITIONS Liposphere Ltd. (IL) 2025-07-09 EP disclosed
WO-2024047645-A1 LIPOSOME-CONTAINING COSMETIC COMPOSITIONS LIPOSPHERE LTD. (IL) 2024-03-07 WO disclosed
WO-2024047647-A1 LIPID ANALOGS, LIPOSOMES COMPRISING SAME AND USES THEREOF LIPOSPHERE LTD. (IL) 2024-03-07 WO disclosed
WO-2024047646-A1 LIPOSOME-CONTAINING COSMETIC COMPOSITIONS LIPOSPHERE LTD. (IL) 2024-03-07 WO disclosed
EP-3969493-B1 POLYURETHANE FOAMS HAVING REDUCED COLD-FLOW EFFECT AND METHOD FOR PRODUCING THE SAME COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) 2023-03-22 EP disclosed
US-20200407500-A1 Flame retardant soft ether foams COVESTRO DEUTSCHLAND AG (DE) 2020-12-31 US disclosed
US-4224338-A Simultaneous fungicidal and miticidal protection of plants employing certain tin compounds THE DOW CHEMICAL COMPANY (US) 1980-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260061093-A1 LIPID ANALOGS, LIPOSOMES COMPRISING SAME AND USES THEREOF PHOSPHO1, SGMS1, SGMS2 CA2 855/4885CA1 1715/4885MAPK1 3465/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.